GW&K Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

GW&K Investment Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9K	Sell	548 -32	-6%	-$530	﹤0.01%	935
2026 Q1	$11K	Buy	580 +76	+15%	+$1.33K	﹤0.01%	865
2025 Q4	$8K	Hold	504	–	–	﹤0.01%	894
2025 Q3	$7K	Hold	504	–	–	﹤0.01%	910
2025 Q2	$8K	Hold	504	–	–	﹤0.01%	878
2025 Q1	$7K	Hold	504	–	–	﹤0.01%	874
2024 Q4	$7K	Hold	504	–	–	﹤0.01%	847
2024 Q3	$7K	Sell	504 -40	-7%	-$567	﹤0.01%	838
2024 Q2	$7K	Hold	544	–	–	﹤0.01%	808
2024 Q1	$8K	Buy	544 +159	+41%	+$2.31K	﹤0.01%	766
2023 Q4	$5K	Hold	385	–	–	﹤0.01%	827
2023 Q3	$6K	Hold	385	–	–	﹤0.01%	775
2023 Q2	$6K	Buy	+385	New	+$6.31K	﹤0.01%	771

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

GW&K Investment Management's TAK Position: Q2 2026 in Review

GW&K Investment Management reduced its Takeda Pharmaceutical (TAK) stake by 5.5% in Q2 2026, selling an estimated $530 and leaving 548 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

GW&K Investment Management first reported a position in TAK in Q2 2023 and has held it in 13 quarters since. The position peaked at $11K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

GW&K Investment Management held 548 shares of Takeda Pharmaceutical worth $9K as of Q2 2026.
GW&K Investment Management sold 32 Takeda Pharmaceutical shares in Q2 2026, an estimated $530.
Takeda Pharmaceutical made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #935 holding.
GW&K Investment Management first reported a position in Takeda Pharmaceutical in Q2 2023 and has held it in 13 quarters since.
GW&K Investment Management's Takeda Pharmaceutical position peaked at $11K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.